Search results
Understanding the Beta Thalassemia Minor Trait
Verywell Health via Yahoo News· 10 months agoBeta thalassemia minor—also known as beta thalassemia trait or B thalassemia—is a blood disorder. It lowers your blood's level of hemoglobin, an...
What Is Beta Thalassemia?
Health via Yahoo News· 4 months agoBeta thalassemia is a blood disorder affecting the production of hemoglobin, the iron-rich protein in red blood cells that carries oxygen through the...
Thalassemia: Understanding This Inherited Blood Disorder
Verywell Health via Yahoo News· 10 months agoThalassemia is a group of blood disorders in which the body doesn't make enough hemoglobin, the...
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
Motley Fool via Yahoo Finance· 5 months agoWith CRISPR Therapeutics (NASDAQ: CRSP) in the news thanks to its successful work in developing...
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
InvestorPlace via Yahoo Finance· 6 months agoThe pharma stock leaders can at times seem overly risk averse with their approach to developing new...
4 First-in-Their-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market...
Motley Fool· 7 months agoWhen looked at over multiple decades, it's difficult to find a more consistent moneymaker than the...
Down 51% in 2023, Here's Why Bluebird Bio Stock Could Soon Double, Says Wall Street
Motley Fool· 11 months agoWall Street analysts' opinions are often well worth considering, but should the small investor...
Beat the Dow Jones With CRISPR Therapeutics Stock
Motley Fool· 1 year agoBack in 2020, CRISPR Therapeutics (NASDAQ: CRSP) left the Dow Jones Industrial Average (DJIA) in the dust. The stock soared more than 150%, while the...
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.
Motley Fool· 11 months agoIf the consensus price target set by Wall Street analysts is to be believed, CRISPR Therapeutics...
3 Monster Stocks in the Making to Buy Right Now
Motley Fool· 2 years agoHere's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Ginkgo Bioworks (NYSE: DNA), and Novocure (NASDAQ: NVCR). Prosper Junior Bakiny (CRISPR Therapeutics): Despite tremendous medical progress ...
